News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
May 12, 2025
·
3 min read
Press Releases
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
May 12, 2025
·
6 min read
Press Releases
BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test
May 12, 2025
·
4 min read
Press Releases
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
May 9, 2025
·
8 min read
Press Releases
Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into Late 2027
May 9, 2025
·
10 min read
Press Releases
Hemostemix at Invest Stuttgart
May 8, 2025
·
7 min read
Press Releases
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
May 8, 2025
·
3 min read
Press Releases
BioMark Diagnostics Announces Uplisting to OTCQB Venture Market
May 8, 2025
·
4 min read
Press Releases
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
May 8, 2025
·
5 min read
Press Releases
Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
May 7, 2025
·
1 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us